For high-risk groups, including patients with existing cardiovascular damage, such as heart failure, arrhythmia, or coronary artery disease, as well as adults aged 65 or older, even this minor increase in HR may have clinical significance
EvaMarie J Introduction to the Blog Summary The blog explores the rise of GLP-1, a weight loss drug initially developed for diabetes management, and its impact on consumer behavior, with a focus on potential implications for brands in industries like food and beverages
We are officially entering the era of the "triple agonist," and the compound leading this shift is Eli Lillys investigational peptide, Retatrutide
I can say they're one of the pioneer brands that's been commercially sold in pharmacies, drugstores, and beauty stores nationwide